Arch Therapeutics’ AC5® Advanced Wound System to be Presented with Honors at 2022 Symposium on Advanced Wound Care (SAWC) Fall
October 11, 2022 06:45 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Announces First Shipments of AC5® Advanced Wound System Under New Reimbursement Support Program
September 23, 2022 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Accepted to Present AC5® Advanced Wound System During Innovation Spotlight at 2022 Symposium on Advanced Wound Care (SAWC)
September 20, 2022 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Launches Multi-Site Clinical Study for AC5® Advanced Wound System
September 07, 2022 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Submits Application to Centers for Medicare and Medicaid Services for AC5® Advanced Wound System
September 01, 2022 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Raises Approximately $3.5 Million in Convertible Note Financing
July 07, 2022 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., July 07, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Wound Dressing Market Size (2022-2028) Deep Dive Analysis of 18+ Countries across 5 Key Regions, Company Profiles and Industry Landscape | The Insight Partners
June 15, 2022 07:12 ET
|
The Insight Partners
New York, June 15, 2022 (GLOBE NEWSWIRE) -- The Insight Partners adds "Wound Dressing Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product Type (Traditional Wound Dressings and...
Arch Therapeutics’ Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC Spring
May 09, 2022 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Renowned Wound Care Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Spring
April 13, 2022 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 13, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Diabetic Foot Ulcer Market Size Worth $7,793.83 Mn, Globally, by 2028 at 7.9% CAGR - Exclusive Report by The Insight Partners
February 11, 2022 08:51 ET
|
The Insight Partners
New York, Feb. 11, 2022 (GLOBE NEWSWIRE) -- The latest research study on “Diabetic Foot Ulcer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Advanced Wound Care Dressings,...